OreStocks

DiagnaMed Holdings Corp. press release

DiagnaMed Holdings Corp. Announces Refiling of Its Annual and Interim Financial Statements and related MD&A

CSE - Canadian National Stock Exchange · Canada · Regulatory Filings

Toronto, Ontario, Nov. 04, 2026 (GLOBE NEWSWIRE) --DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) (the "Company") today announced that it has amended and refiled its annual and interim financial statements and related management's discussion and analysis, as described below.

Refiling of Annual and Interim Financial Statements. The Company has amended and refiled:

its audited consolidated financial statements and related management's discussion and analysis ("MD&A") for the year ended September 30, 2025 (the "Annual Filings"); and

its unaudited interim condensed consolidated financial statements and related MD&A for the period ended June 30, 2026 (the "Interim Filings" and together with the Annual Filings, the "Affected Filings").

The refiling of the Affected Filings follow a review by the British Columbia Securities Commission (the "BCSC") of the Company's continuous disclosure record and relate to its disclosure regarding the Company's transition from an AI technology developer to a natural hydrogen exploration company_._

In addition, disclosures within the Affected Filings have been revised to: (i) consistently state the status of the Company’s legacy technology businesses, including BRAIN AGE®, BrainTremorTM and its other hydrogen technology and commercialization activities; and (ii) provide additional disclosure relating to the Company’s non-brokered private placement of units closed on April 11, 2025.

About DiagnaMed Holdings Corp.

DiagnaMed Holdings Corp. has announced its intention to change its corporate name to GeoHydrogen Corp., subject to regulatory approval. The Company is advancing a portfolio of prospective natural clean hydrogen projects in Ontario and Nova Scotia, Canada, through disciplined scientific exploration and strategic technical partnerships. The Company is focused on identifying naturally occurring clean hydrogen resources by integrating modern geoscience, structural geology and soil gas geochemistry across highly prospective geological environments.

For further information, please contact:

DiagnaMed Holdings Corp.

John Karagiannidis Chief Executive Officer 514-726-7058 info@diagnamed.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking information and are based on expectations, estimates and projections as at the date of this news release. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "plans", "expects", "intends", "anticipates", "believes", "estimates", "aims" or variations of such words and phrases, or statements that certain actions, events or results "may", "could", "should", "would" or "will" occur. Forward-looking statements in this news release include, but are not limited to, statements relating to its planned exploration activities, the completion of the refiling of the Affected Filings and the Company's removal from the Commission's list of issuers in default, and the resolution of the matters raised in the BCSC's review. Forward-looking information is based on management's current expectations and assumptions and is subject to known and unknown risks and uncertainties that could cause actual results to differ materially, including that the BCSC or the Company's auditor may require further changes, and the additional risk factors described in the Company's continuous disclosure filings available on SEDAR+ at www.sedarplus.ca. Readers are cautioned not to place undue reliance on forwardlooking information. The forward-looking information contained in this news release is made as of the date of this news release. The Company undertakes no obligation to update or revise any forwardlooking information, whether as a result of newinformation, future events or otherwise, except as required by applicable securities laws.

Earlier from DiagnaMed Holdings Corp.

More regulatory filings releases